Stifel Explains its Bullish on Fate Therapeutics (FATE) FT596, PT Raised to $118
Tweet Send to a Friend
Stifel analyst Benjamin Burnett raised the price target on Fate Therapeutics (NASDAQ: FATE) to $118.00 (from $79.00) on the belief ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
